Mar 14, 2023 / 12:30PM GMT
Balaji V. Prasad - Barclays Bank PLC, Research Division - Director
Good morning, everyone. Thank you all for joining us for the next session of the Barclays Global Healthcare Conference. And for this session, I have the pleasure of presenting Elanco and Todd Young, the Chief Financial Officer of Elanco, and most particularly delighted that this is Elanco's first participation in our conference. Todd, especially with you. And so as we recently wrapped up a least a couple of weeks ago, what is new with a couple of recaps that we can go into Q&A?
Todd S. Young - Elanco Animal Health Incorporated - Executive VP of Corporate Governance and Strategy & CFO
Sure. So Elanco continues to make very good progress with respect to our execution. 2022 was a very good year with respect to our innovation and the continued delivery of milestones and new products through the pipeline. And on our productivity and we're able to reduce our OpEx by over 10% and maintain a flagger patient declining there.
On the disappointing side, the portfolio didn't perform to the
Elanco Animal Health Inc at Barclays Global Healthcare Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers